Presentations by Tim Sandle


 
Listed below are the main presentations, at conferences or as webinars, delivered by Tim Sandle.

BOOK TIM FOR A WEBINAR, CONFERENCE PRESENTATION OR TRAINING COURSE

To contact Tim about a presentation, conference or webinar, contact Tim via email.


PRESENTATIONS DELIVERED BY TIM (TIMELINE)

  1. 'Bacterial Endotoxin Test: Introducing Methodology' to the Parenteral Society One Day Seminar on LAL Testing, 14th March 2002, Manchester
  2. ‘Future Direction of Pyrogen Testing’ to PharMIG AGM, November 2002, Peterborough
  3. ‘Monitoring – What, When and How Often?’ to Pharmaceutical Cleanrooms, Cambridge, 18th March 2003
  4. ‘Sterility Testing – A Practical Approach’, PharMIG Microbiological Methods Validation Conference, St. Albans, 4th June 2003
  5. ‘Risk Assessment in the Pharmaceutical Industry’, AUDITS 13, Brussels, 16th September 2003
  6. ‘Current Practices in Sterility Testing’, Institute of Validation Technology Microbiology Event of the Year’, December 2003, Dublin
  7. ‘Practical Approaches to Sterility Test Validation’, PharMIG Microbiological Methods Validation Conference, Dublin, 25th March 2004
  8. ‘Three Aspects of LAL Testing: Glucans, Depyropgenation and Water System Qualification’, PharMIG Endotoxin Course, Waltham Abbey, 3rd June 2004
  9. ‘Microbiological Environmental Monitoring in an Isolator Used for Aseptic Filling or Sterility Testing’, AUDITS 15, Brussels, 21st September 2004
  10. ‘Environmental Monitoring Risk Assessment’, Institute of Validation Technology Microbiology Event of the Year’, November 2004, Amsterdam
  11. ‘Constructing a Viable Environmental Monitoring Programme Using a Risk Assessment Approach’, Pharmaceutical Cleanrooms 2005, 6th September 2005, Cambridge
  12. ‘Hot Topics in Pharmaceutical Microbiology’, two interactive sessions, PharMIG Conference, 23rd November 2005
  13. ‘NHS Pay Reform’, National Institute of Biological Standards and Control, South Mims, 18th January 2006
  14. Hot Topics in Pharmaceutical Microbiology’, interactive session, PharMIG Irish Conference, Cork, 8th June, 2006
  15. Distribution of Microbiological Data’, PharMIG Irish Conference, Cork, 7th June, 2006
  16. NHS financial crisis and the Blood Service’, NHS Together, Cambridge, 4th March 2007
  17. Managing a Microbiology Laboratory Training Programme’, presenter on laboratory training programmes, 29th March 2007, PharMIG Training Event, Derby
  18. ‘Applying Failure Mode and Effects Analysis (FMEA) to a Sterility Testing Isolator: A Case Study’, PharMIG Risk Based Management in Pharmaceutical Microbiology, 27th June 2007
  19. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 27th September 2007, PharMIG Training Event, Dublin
  20. ‘Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good documentation practises, 16th October 2008, Pharmig event, Northampton
  21. Best Practices in Microbiological Quality Control and Documentation’, workshop presenter on good quality documentation practises, 1st April 2009, Pharmig event, Cork, Republic of Ireland.
  22. ‘Managing a Microbiology Laboratory Training Programme’, presenter on microbiology laboratory training programmes, 10th June 2009, PharMIG Training Event, Dublin
  23. ‘How to justify doing less monitoring, sampling and testing, and still pass a regulatory inspection’, Pharmig Annual Conference, Nottingham. Session run twice on 18th and 19th November 2009.
  24. ‘Contamination control and pharmaceutical microbiology’, two day course co-hosted with Dr Nigel Halls, run for Nobel Farama, Turkey, 5th & 6th January 2010
  25. Best Practices in Microbiology Training, two sessions, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
  26. Regulatory Developments: Key Points for Microbiology, Pharmig Annual Conference, Nottingham. Session run twice on 24th and 25th November 2010
  27. Cleanrooms and Air Contamination, VIENNI TRAINING, Prune, India, 6th January 2011
  28. ‘The Use of Risk Assessment in the Pharmaceutical Industry – the application if FMEA to a Sterility Testing Isolator: A Case Study’, presented at Pharmaceutical Microbiology Conference (SMi Group), Copthorne Tara Hotel, London, 17th January 2011
  29. ‘Approaching Sterility Testing’, Hulst Pharma Test Expo, Cologne, Germany, 9th February 2011
  30. 'Developments in Regulatory Requirements', ECA 4th Microbiology Conference, Prague, 4th May 2011
  31. 'Environmental Monitoring: sterile / non-sterile', ECA 4th Microbiology Conference, Prague, Czech Republic, 5th May 2011
  32. "How to Justify Doing Less Monitoring, Sampling and Testing and Still Pass a Regulatory Inspection", PDA's 6th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, USA, 18th October 2011
  33. Regulatory Update for Microbiology in 2011, Pharmig Annual Conference, Nottingham. 16th November 2011.
  34. 'A risk based approach to environmental monitoring frequencies', ECA 5th Microbiology Conference, Frankfurt, Germany, 10th May 2012
  35. Regulatory Updates: 2012, Pharmig Irish Conference, Cork, Ireland, 14 June 2012
  36. USP Chapter 1116: environmental monitoring changes, Pharmig Irish Conference, Cork, Ireland, 14 June 2012
  37. ‘Review of Cleanroom Microflora’, NHS Pharmaceutical Quality Assurance Service, Annual Symposium for Technical Services, 25th September 2012, The Ashford International Hotel, Kent, UK
  38. 'Fungal contamination of pharmaceutical products', Pharmaceutical and Healthcare Sciences Society (PHSS) Annual Conference, 11th October 2012, Winchester, UK
  39. USP Chapter 1116: trends in environmental monitoring, Pharmig Annual Conference, Chipping Norton, UK. 6th November 2012
  40. Webinar 'Human Microbiome Project', Microbiology Network (with Tony Cundell and Scott Sutton), 5th March 2013.
  41. 'Fungi in pharmaceutical manufacturing', European Compliance Academy Microbiology Conference, Copenhagen, Denmark, 25th April 2013
  42. 'USP 1116 and its impact upon pharmaceutical microbiology', Pharmig webinar, 1st May 2013
  43. 'The use of control strains for the quality control of culture media', American Pharmaceutical Review Webinar, 14th August 2013 (with Liz Kerrigan of ATCC)
  44. 'Hospitals, Water Systems and Contamination, NHS QA Symposium, Chester, UK. 24th September, 2013
  45. 'Rapid Microbiology Methods and Risk Assessment in the Pharmaceutical Industry', American Pharmaceutical Review Webinar, 16th October 2013 (with Jackie Horrige, BioVigilant)
  46. 'The Human Microbiome Project and Implications for Pharmaceutical Microbiology', PDA 8th Microbiology Conference, Bethesda, MD, USA, 21st October 2013
  47. 'Best Microbiological Practices for cleanroom gowns, gloves and masks', Pharmig Annual Conference, 21st November, 2013
  48. 'Implications of fungal contamination of pharmaceutical products', Pharmig Annual Conference, 21st November, 2013
  49. Best practices in managing microbial excursions and managing out of specification events, webinar for European Pharmaceutical Review, 3rd December 2013
  50. Fungi and pharmaceutical manufacturing, webinar for Pharmig, 19th February 2014
  51. Fungal contamination of pharmaceuticals products, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, 29th April, 2014
  52. Human Microbiome Project, European Compliance Academy, Prague, May 2014
  53. Essential Components for Implementation of a Robust Environmental Monitoring Program (with Anne Connors, Merck Millipore), American Pharmaceutical Review, webinar, 9th July 2014
  54. Contemporary issues in pharmaceutical microbiology, NHS QA Symposium, Kenilworth, UK, 17th September 2014
  55. Media Fill Trials for Aseptic Process Control in Sterile Pharmaceutical Manufacture, webinar for Cleanroom technology (with Colin Booth, ThermoFisher), 24th September 2014
  56. Key points for Cleanroom Disinfection, Gerpac 17th Conference, Presqu’ile de Giens, Hyères, France, 2nd October 2014. (DOI: 10.13140/2.1.5029.76)
  57. Constructing an environmental monitoring program, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014
  58. Risk assessment for environmental monitoring, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014
  59. An environmental monitoring workshop, BioMonitoring Seminar, Environmental Monitoring & Risk Analysis in pharmaceutical Industry, Evoluon, NL-Eindhoven, Netherlands, 9th October 2014 (with Dr. David Roesti).
  60. Cleanroom contamination and disinfection, Pharmig Cleanroom seminar, 28th October 2014, Birmingham, UK
  61. Implications of the human microbiome for cleanrooms, Pharmig Annual Conference - Key Note Speaker, Nottingham, UK, November 2014
  62. Risk Based Environmental Monitoring & Lean Manufacturing, 25th February 2015, Novatek International, Webinar.
  63. Best practices for an environmental monitoring programme, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015
  64. Risk assessment and microbiological risks to pharmaceuticals, Making Pharmaceuticals, National Motorcycle Museum, Birmingham, U.K. April 28, 2015
  65. Webinar - Microbiological Risk of Personnel and Cleanrooms - 28th May 2015
  66. Webinar - Disinfection/Sanitisation Processes: cGMP for Cleaning and Disinfection, 25th June 2015, Pharmig - 25th June 2015
  67. The Problem with Spores in Aseptic Units, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015
  68. Sporicidal Products - a problem of definition and control, presented at 'Sporicides – As Part Of Your Transfer Process' - a Pharmig ./ NHS joint symposium, Birmingham, U.K. on 1st July 2015
  69. Environmental control and environmental monitoring, presented at King's College Hospital NHS Trust, London, U.K., on 24th July 2015
  70. Validation of an Agar Plate Active Microbial Air Sampler According to ISO 14698, Merck webinar, 16th September 2015
  71. The future of ISO 14698, Merck webinar, 16th September 2015
  72. Microbiology Laboratory Myths, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015
  73. Ask the experts panel, 10th PDA Global Microbiology Conference, Bethesda, MD, USA, 19th October 2015
  74. Disinfection Processes for Pharmaceuticals and Surface Sampling on Sanitized Surfaces, Merck webinar, broadcast in Europe and North America (2 sessions) on 22nd October 2015
  75. Bioburden control and objectionable organisms (with Andy Martin), Pharmig Microbiology Conference, Nottingham, U.K., 25th November 2015
  76. Environmental Monitoring Risk Assessment and the Lean Approach, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015
  77. Best practices for aseptic operator practice and gowning, Pharmig Microbiology Conference, Nottingham, U.K., 26th November 2015
  78. ISO 14644 Revision to Parts 1 and 2 (2015 updates), Pharmig webinar, 4th February 2016
  79. Overview of environmental monitoring regulations, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016
  80. Environmental monitoring incubation strategies, Pharmig Environmental Monitoring Course, The Oxfordshire Hotel, Oxford, 3rd March 2016
  81. Bacterial and fungal spores - aseptic processing risks, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016
  82. Selection of disinfectants and sporicides, Pharmig & NHS Sporicidal Meeting, The Oxfordshire Hotel, Oxford, 4th March 2016
  83. Environmental monitoring trending for risk mediation and lean manufacturing, PDA Europe, 10th May 2016 - webinar
  84. Environmental monitoring and microflora - key points, ECA Pharmaceutical Microbiology Conference, Barcelona, 11th May 2016
  85. Investigating Sterility Test Failures, Joint Pharmaceutical Analysis Group, Royal Society for Chemistry, London, 12th May 2016
  86. Environmental monitoring incubation strategies, Pharmig Irish Conference, Fota Island Hotel, Cork, 18th May 2016
  87. Best practices in pharmaceutical gowning, at: PHSS Sterile Products Manufacture June 9, 2016, Hallmark Hotel Manchester Airpor
  88. Best practices for investigating sterility test failures, Pharmig webinar, 6th September 206
  89. Depyrogenation Studies, A3P, Lyon, 18th September 2016
  90. Best practices with microbiological culture media, Pharmig 24th Conference, Nottingham, UK, 17th November 2016
  91. Cleanroom contamination; the Problem Spores and the need for Sporicides, Pharmig conference, Wednesday 15th Feb 2017 - Nailcotte Hall Hotel, Berskwell, Warwickshire
  92. Introduction to cleanrooms, Thursday 16th Feb 2017- Nailcotte Hall Hotel, Berskwell, Warwickshire
  93. Current regulations for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland
  94. Selecting culture media for environmental monitoring, Wednesday 24th May 2017, Pharmig conference, Portmarnock Hotel & Golf Links, Co. Dublin, Ireland
  95. Approaching depyrogenation, Pharmig webinar, 10th August 2017
  96. ‘Fungal Contamination in Pharmaceutical Products and Cleanroom Risk’, webinar for Pharmig, 4th October 201
  97. Environmental monitoring - limitations, incubating, and trending, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
  98. Training in cleanroom contamination, disinfection, and cleaning techniques, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
  99. How to manage sterility test issues and failure investigations, 18th October 2017, Pharmig / Samples H conference: Hot Topics in Pharmaceutical Microbiology for the Adriatic Region, Otocec, Slovenia
  100. Quantitative determination of endotoxin, Pharmig open discussion session, Pharmig Annual Conference, Oxfordshire, UK, 30th November 2017
  101. Risk Based Approach to Environmental Monitoring, webinar for Compliance Online, 19 December 201
  102. Sterility test failure investigations, webinar for Compliance Online, 23 Jan 2018
  103. Review of EU GMP Annex 1, webinar for Compliance Online, 15 March 201
  104. Introduction to disinfectants for GMP industries, Ecolab webinar, 3 April 2018
  105. Fungi and cleanroom contamination, webinar for Compliance Online, 26 April 2018
  106. Pharmig review of Annex 1, Pharmig webinar, 3 May 201
  107. Bacterial and fungal spore risks to pharmaceutical processing, Webinar, Online Compliance Panel, 23rd May 201
  108. Best practices in microbial culture media, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018
  109. Insight into EU GMP Annex 1, Pharmig Irish Conference, Dublin, Ireland, 30th May 2018
  110. Introduction to FMEA: Risk assessment tool for pharmaceuticals, Pharmig risk assessment course, Dublin, Ireland, 31st May 2018
  111. Good Design Practices For Pharmaceutical Water Systems, webinar, Online Compliance, 28th June 2018
  112. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 17th July, Hilton Bangalore Embassy Golf Links, Bangalore
  113. Developing a meaningful environmental monitoring programme, Pharmig Hot Topics Pharmaceutical Microbiology – India, 19th July, Hyatt Hyderabad Hotel, Hyderabad
  114. Introducing the human microbiome, Webinar, Online Compliance Panel, 25th July 2018
  115. Cleanrooms and contamination control, Webinar, Online Compliance Panel, 30th August 2018
  116. Burkholderia cepacia complex: risks to non-pharmaceutical products, Webinar, Online Compliance, 20th September 2018
  117. Pharmaceutical microbiology: Current and future challenges, PDA Europe – Key Note Speaker, Berlin, 15th October 2018
  118. Global Best Practices for Cleaning and Disinfection of Cleanrooms and Disinfection Validation, Online Compliance Panel, 18th October 2018
  119. Cleaning Validation Top Challenges: What you need to know, Novatek International Webinar, 24th October 2018
  120. Pharmaceutical Water Systems: Microbiological Control, Pharmig Webinar, 24th October 2018
  121. Cleanrooms gown and personal control, 22nd November 2018, Online Compliance Panel
  122. Best practices in microbiological culture media, Pharmig Annual Conference, 28th November 2018
  123. Best practices in sterilisation by heat, UCL QP Training London, 5th December 2018
  124. Best practices for sterilisation by filtration, UCL QP Training London, 5th December 2018
  125. Sterility test best practices, UCL QP Training London, 5th December 2018
  126. Best practices for microbial identification, webinar, Compliance Online, 14th December, 2018
  127. Risk assessment case studies for environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13th February 2019
  128. Impact of the microbiome on environmental monitoring, Pharmig Environmental Monitoring Best Practices, Nailcotte Hotel, Birmingham, 13th February 2019
  129. Problem of bacterial and fungal spores in pharmaceutical facilities, Online Compliance Panel, 21st February 2019
  130. Out of Specification Investigations: A New Look at the Topic, 7th March 2019, webinar for Online Compliance Panel
  131. Applying FMEA risk assessment to a sterility testing isolator, 21st March 2019, webinar for Online Compliance Panel
  132. What to expect from the revised EU GMP Annex 1?., Pharmig Croatia Conference, 27th March 2019, Zagreb
  133. Operation of sterility test isolators and validation issues, Pharmig Croatia Conference, 27th March 2109, Zagreb
  134. Cleaning and disinfection of cleanrooms – why e-learning matters, Pharmig Croatia Conference, 27th March 2019, Zagreb
  135. What to expect from the revised EU GMP Annex 1?., Pharmig Slovenia Conference, 28th March 2019, Ljubljana
  136. Operation of sterility test isolators and validation issues, Pharmig Slovenia Conference, 28th March 2019, Ljubljana
  137. Cleaning and disinfection of cleanrooms – why e-learning matters, Slovenia Conference, 28th March 2019, Ljubljana
  138. Introducing Pharmig’s e-learning platform for cleaning and disinfection of cleanrooms, webinar for Pharmig, 18th April 2019
  139. How to justify doing less microbiological sampling and testing, and still pass a regulatory inspection, 25th April 2019, Online Compliance Panel
  140. Best practice in environmental monitoring, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
  141. Aseptic processing challenges panel, Assuring the quality of medicines III: aseptic products, Royal Society of Chemistry, London, 9th May 2019
  142. Microbiological aspects of cleaning validation, Pharmig Irish Conference, Dublin, 15th May 2019
  143. Best practices in endotoxin testing open discussion, Pharmig Irish Conference, Dublin, 15th May 2019 (run twice)
  144. Three case studies relating to endotoxin contamination in water systems, Pharmig Pharmaceutical water systems, Dublin, 16th May 2019
  145. Practical Approaches to Sterility Test Validation: Overcoming difficult products, Online Compliance Panel webinar, 24th May 2019
  146. Cleanroom gowning and personnel control, Pharmig webinar, 12th June 2019
  147. Handling data integrity in the microbiology laboratory, Online Compliance Panel webinar, 20th June 2019
  148. Developing an environmental monitoring programme, Online Compliance Panel webinar, 11th July
  149. Developing a contamination control study for pharmaceuticals and healthcare, 1st August 2019, Online Compliance Panel webinar
  150. Fungal Contamination and Pharmaceutical Products Recall, 19th September 2019, Online Compliance Panel webinar
  151. Supplier Oversight and Quality Control for Patient Safety, Voices In Validation, 4th October 2019
  152. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 15th October 2019 Radisson, Hyderabad, India
  153. Risk assessment and environmental monitoring. At Pharmig’s Best Practices in Microbiological Environmental Monitoring, 16th October 2019, Hilton, Mumbai, India
  154. Fungal contamination of pharmaceutical products, webinar compliance online, 19th October 2019
  155. Environmental monitoring – best practices, Pharmig annual conference, 13th November 2019, Nottingham UK
  156. New regulatory standards and updates, Pharmig annual conference, 14th November 2019, Nottingham UK
  157. Human microbiome and its implications for cleanrooms, NHS QA and Technical Services Symposium, Bristol, UK, 27th November, 2019 – Key note speaker
  158. What to Expect From the New EU GMP Annex 1, Online Compliance Panel webinar, 9th January 2020
  159. Risk assessment of aging pharmaceutical facilities, Pharmig webinar, 6th February 2020
  160. The lean laboratory and a new approach for environmental monitoring, Online Compliance Panel, 13th February 2020
  161. The problem with bacterial and fungal spores for pharmaceutical cleanrooms, Assentpro webinar, 25th February 2020
  162. Annex 1 2020 revision – an overview, Voices In Validation, 12th March 2020
  163. Three case studies relating to endotoxin contamination in water systems, Pharmig Control of Pharmaceutical Water Systems, Virtual Conference, 31st March 2020
  164. EU GMP and the implications for sterile products manufacture, RRSL webinar, 1st April 2020
  165. Introducing Annex 1 and updates for sterility assurance, UCL QP webinar, 15th April 2020
  166. Microbiological aspects of cleaning validation, Pharmig webinar, 30th April 2020
  167. Focal points for the release of sterile products, RSSL webinar, 6th May 2020
  168. Round up of new standards and regulations during the past year, Pharmig Spring Conference, 20th May 2020
  169. Latest draft of Annex 1 – what do we do next?, Pharmig Spring Conference, 21st May 2020
  170. Risk assessment tools for environmental monitoring, Pharmig Best Practices in Environmental Monitoring 27th May 2020
  171. Incubation strategies for environmental monitoring, Pharmig Best Practices in Environmental Monitoring, virtual conference, 28th May 2020
  172. Investigating sterility test failures, RRSL webinar, 4th June 2020
  173. Best practices for cleanroom gowning, Pharmig webinar, 4th June 2020
  174. Microbiological Aspects of Cleaning Validation, 5th June 2020, Cleaning Validation and Environmental Monitoring, Volanthen Conferences, Prague.
  175. Anatomy of Annex 1, UCL, 2nd July 2020
  176. Best practices in environmental monitoring, RSSL webinar, 2nd July 2020
  177. Investigating sterility test failures, IPSE India, 4th July 2020
  178. Selection and qualification of alternative and rapid microbiological methods, PHarmig rapid methods online workshop, 13th August 2020
  179. Great myths of Pharmaceutical Microbiology, Pharmig webinar, 27th August 2020
  180. EU GMP Annex 1 Current guidance and the new draft: Implications for sterile pharmaceutical products manufacturing, PDA New England Chapter, 3rd September 2020, Boston, U.S.
  181. Blood and Plasma Products, UCL, London, 8th September 2020
  182. Cleaning validation for the food industry, Campden Food Research Association, 6th October 2020, online conference
  183. Cleanroom design, UCL, London, 6th October 2020 (run multiple times)
  184. Environmental monitoring, UCL, London, 6th October 2020 (run multiple times)
  185. Disinfection and preservation, UCL, London, 6th October 2020 (run multiple times)
  186. COVID19 preventative measures for pharmaceuticals, Pharmig Adriatic Conference, 21st October 2020
  187. Best practices with microbiological culture media, Pharmig Adriatic Conference, 22nd October 2020
  188. Consideration of COVID-19 Prevention Measures for those working in GMP Pharmaceuticals and Healthcare Facilities, RRSL webinar, 22nd October 2020
  189. Microbiological concerns in relation to cleaning validation, IPSE India, 24th October 2020
  190. Best practices for cleaning and disinfection of GxP environments, RSSL webinar, 18th November 2020
  191. Prerequisites for Testing, including control of culture media and method validation, HPRA training session for GMP inspectors, 19th November 2020 (with Edel Fitzmaurice)
  192. Microbial identifications, HPRA training session for GMP inspectors, 19th November 2020 (with Edel Fitzmaurice)
  193. Environmental Monitoring, HPRA training session for GMP inspectors, 19th November 2020
  194. Sterility Testing, HPRA training session for GMP inspectors, 20th November 2020
  195. Biological Indicators, HPRA training session for GMP inspectors, 20th November 2020
  196. Case Studies Microbial Deviations /Contamination. HPRA training session for GMP inspectors, 20th November 2020 (with Edel Fitzmaurice)
  197. Microbiological concerns with cleaning validation (Validacao de Limpeza), PDA Brazil, São Paulo, 23rd November 2020
  198. Hygienic design: Best practices for pharmaceutical facilities, 30th November 2020, Cleaning Validation Conference, Vonlanthen Conferences, Austria
  199. Sterility testing: Overcoming difficult products, RSSL webinar, 3rd December 2020
  200. More pharmaceutical microbiology myths, Pharmig Annual Conference, 3rd December 2020
  201. Brexit and implications for the Qualified Person, UCL, London. 9th January 2021
  202. E-cigarettes, vaping products, and microbial contamination, Keeping Learning at BPL, 14th January 2021
  203. Veil of compliance? What exactly does a facemask do and why should I wear one?, Keeping Learning at BPL, 8th August 2020
  204. Introducing the human microbiome, Keeping Learning at BPL, 9th April, 2020
  205. COVID-19: Does it require a new standard?,3rd Annual Cleanroom Design and Engineering Forum, TBM Group, Czech Republic, January 2021
  206. What’s lurking in the water?, Pharmig webinar, 11th February, 2021
  207. Investigating Endotoxin Contamination in Pharmaceutical Water Systems, IPSE webinar, 12th February 2021  
  208. EN17141 – what can we learn from the new standard?, PDA New England chapter webinar, 3rd March 2021
  209. Pharmaceutical products recalls, UCL, London, 6th March 2021
  210. Evaluation of Milliflex Quantum for the testing of pharmaceutical water, Merck webinar, Germany,16th March 2021   
  211. The key focal points about EU GMP Annex 1, RSSL, 24th March, 2021 
  212. Best data integrity practices for microbiology, Pharmig webinar, 1st April 2021
  213. Investigating Burkholderia cepacia, Pharmig webinar, 13th April 2021
  214.  Key points from EU GMP Annex 1, PDA West Coast Chapter, webinar, 15th April 2021  
  215. Anatomy of a Contamination Control Strategy, Ecolab Life Science, Global Audience Broadcast, 26th April 2021 
  216. Quality Risk Management for Pharmaceuticals, RSSL, 27th April 2021  
  217. Validation and investigation of the sterility test, PDA Brazil, 24th May 2021
  218.  Application of environmental isolates, Pharmig, 25th May 2021
  219.  Developing a contamination control strategy, RSSL,26th May 2021  
  220. Risk considerations for the presence of pyrogens and the need for the MAT test in pharmaceutical processing, Merck Pharmaceutical Microbiology international Conference, 16th (North America) and 17th (Europe) June 2021, online 
  221. Practical solutions to real events: Endotoxin contamination of water systems, Endotoxins: LAL today / LAL tomorrow Pharmig conference, 23rd June 2021. Online 
  222. Best practices for out of specification investigations, Pharmig webinar, 29th June 2021 
  223. Cleanroom design: The key factors, RRSL webinar, 30th June 2021 
  224. Designing a biocontamination control standard, Pharmig webinar, 8th July 2021
  225. Environmental monitoring: Understanding your process. AB Scientific / Sherpa Pharma, 22nd July 2021 
  226.  Protecting products from people in pharmaceutical cleanrooms, 29th July 2021, RSSL 
  227.  Sterility testing: Validation and failure investigations, 6th August 2021, U.S. FDA CBER specially requested training webinar    
  228. Factors for success: Rapid microbiological methods, PDA Singapore, 16th September 2021
  229.  Sporicides and spore contamination, Pharmig webinar, 22nd September 2021


     
 

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers